Spine implant developer Accelus announced today that it appointed Kevin McGann and Bernie Haffey to its board of directors. The Palm Beach Gardens, Florida-based company said the new appointments provide a strategic enhancement and align with its mission. Accelus aims to deliver innovative spinal solutions that elevate the surgical experience and improve patient outcomes. It […]
Accelus
Accelus picks up $20M to support expandable spine implant tech
Accelus announced that it received a significant financial investment through a $20 million debt facility from Symbiotic Capital. Palm Beach Gardens, Florida-based Accelus says the strategic funding represents a critical milestone in the company’s journey. It aims to establish itself as the global market leader in expandable spinal implant solutions. Adding the capital strengthens its […]
How did medtech SPAC mergers fare?
Over the past few years, special purpose acquisition corporations (SPACs) have found their way into the medtech space. These businesses — built to bring private companies public — raise initial public offerings (IPOs). They then go and acquire existing companies, taking them public in the process. The value of these mergers varies, but some in […]
FDA clears Remi robot from Accelus for use with most spine surgery imaging systems
Accelus announced that it received FDA 510(k) clearance for its Remi robotic navigation system for use with GE OEC 9900 C-Arm fluoroscopic imaging systems. Palm Beach Gardens, Florida–based Accelus designed Remi for robotic targeting and navigation. It assists surgeons with robotic-assisted pedicle screw placement in the lumbar spine. The system utilizes a near-field optical tracking […]
Spine surgery company Accelus set for $482M SPAC merger
Accelus announced that it entered into a definitive business combination agreement with CHP Merger Corp. worth approximately $482 million. Upon the closing of the agreement — expected for early 2022 — CHP Merger Corp., a special purpose acquisition company (SPAC), will be renamed Accelus. Accelus co-founder and CEO Chris Walsh, formerly of Stryker and NuVasive, […]
